Paramagnetic Immunobeads for ASC Isolation Without Electricity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for isolating adipose-derived stem cells (ASCs) require electricity for instrumentation and use costly enzymes like collagenase, making it difficult to deliver stem cell-based regenerative therapies to populations without access to electricity.

Innovation Solution

The use of paramagnetic immunobeads (PIBs) that selectively bind to ASC-specific antigens, allowing for the isolation of ASCs without the need for electricity or enzymatic digestion, using a magnetic field to immunoprecipitate the stromal vascular fraction (SVF).

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If mechanical and enzymatic techniques are used to isolate SVF, then isolation effectiveness is improved, but requirement for electricity and costly enzymes increases

Engineering Contradiction:
Improveisolation effectivenessVSAvoidelectricity requirement
Core Design Contradiction:
ProductivityVSUse of energy by moving object

Solution Approach 1:

The patent replaces mechanical techniques (centrifugation requiring electric centrifuges) and enzymatic techniques (collagenase digestion) with a magnetic field-based immunoprecipitation system. Paramagnetic beads conjugated to anti-CD34 antibodies directly capture target cells through magnetic attraction, eliminating the need for electric-powered instrumentation while maintaining high isolation effectiveness.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces paramagnetic beads as an intermediary carrier that bridges the magnetic field and target cells. These beads are conjugated to specific antibodies (anti-CD34) and serve as magnetic carriers that can be manipulated by external magnetic fields to isolate SVF cells without requiring direct mechanical or enzymatic intervention.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If enzymatic digestion is used to isolate SVF, then cell separation is improved, but cost and safety concerns increase

Engineering Contradiction:
Improvecell separationVSAvoidcost and safety
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent replaces enzymatic digestion (chemical method) with magnetic field-based immunoprecipitation (physical method). Instead of using collagenase, trypsin, or dispase enzymes that require costly GMP-grade purification and pose safety risks, the invention uses paramagnetic beads with surface-conjugated antibodies that are manipulated by magnetic fields to achieve cell separation without enzymatic agents.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces paramagnetic beads as an intermediary that enables cell separation through magnetic attraction rather than enzymatic digestion. These beads are functionalized with specific antibodies (anti-CD34, anti-CD45, anti-CD14) that selectively bind to target cell surface markers, allowing for specific and safe cell isolation without exposing patients to enzymatic safety risks.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If electricity-dependent instrumentation is used for cell isolation, then processing capability is improved, but accessibility to populations without electricity decreases

Engineering Contradiction:
Improveprocessing capabilityVSAvoidaccessibility
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The patent replaces electric-powered instrumentation with a passive magnetic field-based system. The isolation process uses external magnets to manipulate paramagnetic bead-conjugated cells through magnetic attraction and repulsion forces, eliminating the need for electric centrifuges, pumps, or other powered equipment. This enables cell isolation in resource-limited settings without compromising processing capability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent enables the isolation system to perform separation functions using passive magnetic fields rather than active electric instrumentation. The paramagnetic beads automatically respond to magnetic field gradients, allowing cell isolation to occur through simple magnetic attraction without requiring external power sources, control systems, or complex instrumentation.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method effectively isolates ASCs with greater efficacy compared to enzyme-based methods, as demonstrated by higher cell counts and comparable colony formation and morphology in culture, without requiring electrical power.

Implementation Method 1

A magnetic field can then be applied to the lipoaspirate to immunoprecipitate a stromal vascular fraction (SVF)

Methodology Applied
Scientific EffectMagnetic field: Magnetic Field

Implementation Method 2

the magnetic material is a paramagnetic spherical polymer particle

Methodology Applied
Scientific EffectParamagnetism: Superparamagnetism

Data Source

PatentUS12270808B2Paramagnetic immunobeads for the isolation of human adipose-derived stem cells
Publication Date: 2025.04.08 UNIV OF FLORIDA RESEARCH FOUNDATION INC
  • US12270808B2 patent drawing
  • US12270808B2 patent drawing
  • US12270808B2 patent drawing

AI summary

Disclosed herein are compositions, devices, and methods for isolating human Adipose-derived stem cells (ASCs) without either electricity or enzymatic digestion. In particular, a paramagnetic immunobead (PIB) for isolating human ASCs is disclosed. In some embodiments, the PIB displays on its surface one or more antibodies that selectively bind ASC-specific antigens. Also disclosed is a method for isolating human ASCs using the disclosed PIBs.